Sukunya Ross
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sukunya Ross has a total of 161 co-authors. Here are the top co-authors by number of shared publications:
- Gareth Michael Ross
Department of Chemistry, Faculty of Science, Naresuan University, Phitsanulok 65000, Thailand
34 shared publications - Jarupa Viyoch
Department of Pharmaceutical Technology, Center of Excellence for Innovation in Chemistry, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok 65000, Thailand
15 shared publications Sararat Mahasaranon
Biopolymer Group, Center for Biomaterials and Commercial Innovation, Department of Chemistry, Faculty of Science Naresuan University Phitsanulok Thailand
13 shared publications- Paul D. Topham
Aston Institute for Membrane Excellence Aston University Birmingham UK
12 shared publications - Sararat Mahasaranon
Biopolymer Group, Department of Chemistry, Faculty of Science, Naresuan University, Phitsanulok 65000, Thailand
10 shared publications - Jirapas Jongjitwimol
Department of Medical Technology, Faculty of Allied Health Sciences, Naresuan University, Phitsanulok 65000, Thailand
9 shared publications
Latest Publications
- Open Access
Bioinspired Suction-Cup Architecture Modulates Hydration and Pomegranate-Extract Release from NVP/HEMA/CMC Hydrogels
Surface architecture may tune hydrogel transport without changing formulation. Flat and suction-cup N-vinylpyrrolidone/2-hydroxyethyl methacrylate/carboxymethyl cellulose (NVP/HEMA/CMC) hydrogels prepared from the same nominal formulation were compared for hydration, equilibrium water content, pomegranate-extract uptake, and 60 min release. Suction-cup hydrogels showed greater short-term swelling (38.7 ± 0.7%) than flat hydrogels (31.4 ± 0.6%), a 23.1% increase, while equilibrium water contents remained similar. Apparent extract uptake, estimated from loading-solution depletion, was 20.45 and 15.74 mg/g hydrated hydrogel for suction-cup and flat formats, respectively. After 60 min, cumulative apparent pomegranate-extract-equivalent release was 6.976 ± 0.681 and 4.208 ± 0.354 mg, respectively, representing a 65.8% increase. These values corresponded to approximately 17.6% and 15.2% of estimated initial loadings. Indirect-extract testing showed minimum viabilities of 86.24% for HaCaT cells and 71.01% for human dermal fibroblasts, exceeding the 70% ISO 10993-5 criterion. Overall, suction-cup architecture increased early swelling, estimated uptake, and cumulative release without altering formulation. Although the individual contributions of surface area, local thickness, liquid retention, and diffusion paths could not be separated, the results demonstrate that architectural modification can enhance early hydration and extract uptake and release while preserving the hydrogel formulation.
Open AccessBioinspired Suction-Cup Architecture Modulates Hydration and Pomegranate-Extract Release from NVP/HEMA/CMC Hydrogels
Surface architecture may tune hydrogel transport without changing formulation. Flat and suction-cup N-vinylpyrrolidone/2-hydroxyethyl methacrylate/carboxymethyl cellulose (NVP/HEMA/CMC) hydrogels prepared from the same nominal formulation were compared for hydration, equilibrium water content, pomegranate-extract uptake, and 60 min release. Suction-cup hydrogels showed greater short-term swelling (38.7 ± 0.7%) than flat hydrogels (31.4 ± 0.6%), a 23.1% increase, while equilibrium water contents remained similar. Apparent extract uptake, estimated from loading-solution depletion, was 20.45 and 15.74 mg/g hydrated hydrogel for suction-cup and flat formats, respectively. After 60 min, cumulative apparent pomegranate-extract-equivalent release was 6.976 ± 0.681 and 4.208 ± 0.354 mg, respectively, representing a 65.8% increase. These values corresponded to approximately 17.6% and 15.2% of estimated initial loadings. Indirect-extract testing showed minimum viabilities of 86.24% for HaCaT cells and 71.01% for human dermal fibroblasts, exceeding the 70% ISO 10993-5 criterion. Overall, suction-cup architecture increased early swelling, estimated uptake, and cumulative release without altering formulation. Although the individual contributions of surface area, local thickness, liquid retention, and diffusion paths could not be separated, the results demonstrate that architectural modification can enhance early hydration and extract uptake and release while preserving the hydrogel formulation.
- 7 September 2026
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 9 (18) , 8746-8764
Hybrid Silk Fibroin/Poly(lactic acid) Macromer Nanogels for Advanced Drug Delivery: Influence of Organic and Silsesquioxane Crosslinker Topologies on Molecular Organization and Physicochemical Properties
Molecular orientation and structural topology play critical roles in determining the performance of biomacromolecular nanocarriers for controlled drug delivery. Herein, the influence of organic and silsesquioxane crosslinker topologies on hybrid nanogels composed of an allyl-functionalized silk fibroin macromer (SFM) and poly(lactic acid) macromer (PLAM) was systematically investigated. Three crosslinkers with distinct molecular architectures were employed: a linear organic framework (N,N′-methylenebisacrylamide, MBAm), a ladder-like silsesquioxane [LD-4Ph-2MeVi, (LDSQ)], and a well-defined double-decker silsesquioxane [(DDSQ-2MeVi, (DDSQ)]. Crosslinker topology markedly influenced nanogel morphology and surface characteristics, producing average particle diameters of approximately 292 nm [NG1(MBAm)], 688 nm [NG2(LDSQ)], and 315 nm [NG3(DDSQ)], while silsesquioxane-containing nanogels exhibited negative zeta potentials (–10 to –30 mV). High-resolution XPS, HRTEM, and XRD analyses revealed that the rigid-cage-like DDSQ topology promotes localized molecular ordering and more compact chain packing of β-sheet-rich SFM and PLAM chains within the hybrid nanogel network. These structural differences significantly affected pH-responsive biphasic Rhodamine B release. At physiological pH 7.4, electrostatic interactions between the nanogel matrix and cargo molecules minimized premature release, whereas acidic conditions (pH 5.5) induced protonation-mediated swelling and accelerated molecular diffusion, resulting in accelerated release. Among all formulations, NG3(DDSQ) exhibited the highest cumulative release efficiency, which was attributed to its ordered network structure and stable nanochannel-like free volume. Furthermore, all nanogels demonstrated excellent cytocompatibility (>98% viability) and significantly promoted fibroblast proliferation (p < 0.05). These findings establish a clear topology–structure–property relationship in silk fibroin/PLA hybrid nanogels and demonstrate that silsesquioxane topology is an effective molecular design parameter for developing pH-responsive biomacromolecular drug delivery systems.
- 7 September 2026
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 9 (18) , 8746-8764
Hybrid Silk Fibroin/Poly(lactic acid) Macromer Nanogels for Advanced Drug Delivery: Influence of Organic and Silsesquioxane Crosslinker Topologies on Molecular Organization and Physicochemical Properties
Molecular orientation and structural topology play critical roles in determining the performance of biomacromolecular nanocarriers for controlled drug delivery. Herein, the influence of organic and silsesquioxane crosslinker topologies on hybrid nanogels composed of an allyl-functionalized silk fibroin macromer (SFM) and poly(lactic acid) macromer (PLAM) was systematically investigated. Three crosslinkers with distinct molecular architectures were employed: a linear organic framework (N,N′-methylenebisacrylamide, MBAm), a ladder-like silsesquioxane [LD-4Ph-2MeVi, (LDSQ)], and a well-defined double-decker silsesquioxane [(DDSQ-2MeVi, (DDSQ)]. Crosslinker topology markedly influenced nanogel morphology and surface characteristics, producing average particle diameters of approximately 292 nm [NG1(MBAm)], 688 nm [NG2(LDSQ)], and 315 nm [NG3(DDSQ)], while silsesquioxane-containing nanogels exhibited negative zeta potentials (–10 to –30 mV). High-resolution XPS, HRTEM, and XRD analyses revealed that the rigid-cage-like DDSQ topology promotes localized molecular ordering and more compact chain packing of β-sheet-rich SFM and PLAM chains within the hybrid nanogel network. These structural differences significantly affected pH-responsive biphasic Rhodamine B release. At physiological pH 7.4, electrostatic interactions between the nanogel matrix and cargo molecules minimized premature release, whereas acidic conditions (pH 5.5) induced protonation-mediated swelling and accelerated molecular diffusion, resulting in accelerated release. Among all formulations, NG3(DDSQ) exhibited the highest cumulative release efficiency, which was attributed to its ordered network structure and stable nanochannel-like free volume. Furthermore, all nanogels demonstrated excellent cytocompatibility (>98% viability) and significantly promoted fibroblast proliferation (p < 0.05). These findings establish a clear topology–structure–property relationship in silk fibroin/PLA hybrid nanogels and demonstrate that silsesquioxane topology is an effective molecular design parameter for developing pH-responsive biomacromolecular drug delivery systems.
- Open Access
Modulating Oxidative Stress and Inflammatory Responses of Aloe vera–Silk Fibroin–Chitosan Gel Formulation in Macrophages and Diabetic Fibroblasts Under Chronic Inflammatory-like Conditions
Chronic and diabetic wounds are characterized by persistent inflammation, excessive oxidative stress, and impaired cellular responses, collectively leading to delayed tissue repair. This study aimed to evaluate a thermoresponsive gel incorporating Aloe vera (AV) extracts and silk fibroin (SF), focusing on its biocompatibility, anti-inflammatory, antioxidant, and pro-regenerative potential. The AV: SF mixture and gel formulation were evaluated in macrophage-like THP-1 cells, and human diabetic dermal fibroblasts (HDdF) under non-induced and LPS/IL-6/TNF-α-induced inflammatory conditions. Both formulations maintained high cell viability across all cell types, indicating good biocompatibility. Under inflammatory conditions, both the AV: SF mixture and gel significantly reduced intracellular ROS levels and suppressed TNF-α and IL-1β secretion. In addition, NF-κB p65 activation was attenuated in both macrophage-like THP-1 cells and HDdF. Macrophage-like THP-1 cells displayed the M2 (CD80low/CD206high) phenotype, indicating modulation of macrophage polarization toward wound remodeling and repair. Overall, the AV: SF-based gel system demonstrated coordinated antioxidant, anti-inflammatory, and pro-regenerative effects in vitro. These findings support its potential as a multifunctional biomaterial for modulating inflammation-associated cellular dysfunction in chronic and diabetic wound environments.
Open AccessModulating Oxidative Stress and Inflammatory Responses of Aloe vera–Silk Fibroin–Chitosan Gel Formulation in Macrophages and Diabetic Fibroblasts Under Chronic Inflammatory-like Conditions
Chronic and diabetic wounds are characterized by persistent inflammation, excessive oxidative stress, and impaired cellular responses, collectively leading to delayed tissue repair. This study aimed to evaluate a thermoresponsive gel incorporating Aloe vera (AV) extracts and silk fibroin (SF), focusing on its biocompatibility, anti-inflammatory, antioxidant, and pro-regenerative potential. The AV: SF mixture and gel formulation were evaluated in macrophage-like THP-1 cells, and human diabetic dermal fibroblasts (HDdF) under non-induced and LPS/IL-6/TNF-α-induced inflammatory conditions. Both formulations maintained high cell viability across all cell types, indicating good biocompatibility. Under inflammatory conditions, both the AV: SF mixture and gel significantly reduced intracellular ROS levels and suppressed TNF-α and IL-1β secretion. In addition, NF-κB p65 activation was attenuated in both macrophage-like THP-1 cells and HDdF. Macrophage-like THP-1 cells displayed the M2 (CD80low/CD206high) phenotype, indicating modulation of macrophage polarization toward wound remodeling and repair. Overall, the AV: SF-based gel system demonstrated coordinated antioxidant, anti-inflammatory, and pro-regenerative effects in vitro. These findings support its potential as a multifunctional biomaterial for modulating inflammation-associated cellular dysfunction in chronic and diabetic wound environments.
- Open Access
Chitosan–Silk Fibroin Hydrogel Scaffold Incorporating Bioactive Aloe vera and Mimosa Complex for Cartilage-Supportive Applications
A composite hydrogel scaffold comprising chitosan, silk fibroin, Aloe vera extract, and Mimosa complex was fabricated and thoroughly characterized. Upon freeze-drying, the scaffolds displayed a uniform cylindrical geometry with a highly porous, interconnected polymeric network. Quantitative image analysis revealed a mean pore diameter of 43.09 ± 2.27 µm alongside an overall porosity of 61.4 ± 6.2%. ATR-FTIR and XRD analyses confirmed successful inclusion of the complex formation and the incorporation of all constituents into the final formulation. The scaffold exhibited a compressive modulus of 46.63 ± 22.71 kPa (dry) and 5.40 ± 3.73 kPa (hydrated), with a swelling ratio of 756.62 ± 114.08%, supporting its suitability for physiological applications. TGF-β3 loading via adsorption yielded an entrapment efficiency of approximately 79.18%, reflecting effective physical immobilization throughout the polymer matrix. Cytocompatibility was subsequently assessed using an indirect contact model combined with an MTT assay, both of which confirmed that TGF-β3-loaded scaffolds exerted no cytotoxic effects on chondrocytes. After 28 days in culture, scanning electron microscopy revealed pronounced cell adhesion, preservation of rounded cell morphology, and ECM deposition along pore walls and throughout interconnected channels. Immunofluorescence analysis further demonstrated a time-dependent accumulation of aggrecan and collagen type II within the three-dimensional scaffold architecture. Collectively, these findings suggest that the developed composite hydrogel scaffold is well-suited for cartilage-related in vitro culture applications.
Open AccessChitosan–Silk Fibroin Hydrogel Scaffold Incorporating Bioactive Aloe vera and Mimosa Complex for Cartilage-Supportive Applications
A composite hydrogel scaffold comprising chitosan, silk fibroin, Aloe vera extract, and Mimosa complex was fabricated and thoroughly characterized. Upon freeze-drying, the scaffolds displayed a uniform cylindrical geometry with a highly porous, interconnected polymeric network. Quantitative image analysis revealed a mean pore diameter of 43.09 ± 2.27 µm alongside an overall porosity of 61.4 ± 6.2%. ATR-FTIR and XRD analyses confirmed successful inclusion of the complex formation and the incorporation of all constituents into the final formulation. The scaffold exhibited a compressive modulus of 46.63 ± 22.71 kPa (dry) and 5.40 ± 3.73 kPa (hydrated), with a swelling ratio of 756.62 ± 114.08%, supporting its suitability for physiological applications. TGF-β3 loading via adsorption yielded an entrapment efficiency of approximately 79.18%, reflecting effective physical immobilization throughout the polymer matrix. Cytocompatibility was subsequently assessed using an indirect contact model combined with an MTT assay, both of which confirmed that TGF-β3-loaded scaffolds exerted no cytotoxic effects on chondrocytes. After 28 days in culture, scanning electron microscopy revealed pronounced cell adhesion, preservation of rounded cell morphology, and ECM deposition along pore walls and throughout interconnected channels. Immunofluorescence analysis further demonstrated a time-dependent accumulation of aggrecan and collagen type II within the three-dimensional scaffold architecture. Collectively, these findings suggest that the developed composite hydrogel scaffold is well-suited for cartilage-related in vitro culture applications.
- 6 May 2026
- Published by Wiley in Polymer International
- Vol. 75 (10) , 881-904
Silk sericin as a functional biopolymer: From polymer chemistry to biomedical translation
Silk sericin (SS), once regarded as a byproduct of silk processing, has recently gained attention as a functional biopolymer owing to its intrinsic biocompatibility and versatile chemical functionality. This review presents a polymer‐ and chemistry‐driven perspective on SS, emphasizing how its amino acid composition and abundant reactive groups (e.g. hydroxyl, carboxyl and amine functionalities) enable precise chemical modification and materials design. Key modification strategies, including methacrylation, acrylation, hydrazide functionalization and carboxylation, are critically discussed in relation to their effects on solubility, crosslinking behavior, structural stability and structure–property relationships. The review further examines how these chemically tailored SS systems can be processed into diverse polymeric formats, such as films, nanospheres, nanofibrous membranes and three‐dimensional scaffolds. In addition, recent advances in SS‐based composites, crosslinking strategies and network formation are highlighted, illustrating their roles in enhancing mechanical performance, processability and functional stability. Translational considerations, including scalability, reproducibility and regulatory challenges, are also addressed. Overall, this review positions silk sericin as a chemically tunable biopolymer platform, bridging fundamental polymer chemistry with emerging biomedical and translational applications. © 2026 Society of Chemical Industry.
- 6 May 2026
- Published by Wiley in Polymer International
- Vol. 75 (10) , 881-904
Silk sericin as a functional biopolymer: From polymer chemistry to biomedical translation
Silk sericin (SS), once regarded as a byproduct of silk processing, has recently gained attention as a functional biopolymer owing to its intrinsic biocompatibility and versatile chemical functionality. This review presents a polymer‐ and chemistry‐driven perspective on SS, emphasizing how its amino acid composition and abundant reactive groups (e.g. hydroxyl, carboxyl and amine functionalities) enable precise chemical modification and materials design. Key modification strategies, including methacrylation, acrylation, hydrazide functionalization and carboxylation, are critically discussed in relation to their effects on solubility, crosslinking behavior, structural stability and structure–property relationships. The review further examines how these chemically tailored SS systems can be processed into diverse polymeric formats, such as films, nanospheres, nanofibrous membranes and three‐dimensional scaffolds. In addition, recent advances in SS‐based composites, crosslinking strategies and network formation are highlighted, illustrating their roles in enhancing mechanical performance, processability and functional stability. Translational considerations, including scalability, reproducibility and regulatory challenges, are also addressed. Overall, this review positions silk sericin as a chemically tunable biopolymer platform, bridging fundamental polymer chemistry with emerging biomedical and translational applications. © 2026 Society of Chemical Industry.
- Open Access
Artocarpin: Multi-Targeted Mechanisms Against UV-Induced Skin Aging and Its Skin Penetration Enhancement Strategies
Artocarpin, a prenylated flavonoid isolated from Artocarpus altilis heartwood, has emerged as a promising multi-targeted bioactive compound for combating UV-induced skin aging. This review provides a comprehensive overview of the molecular mechanisms and photoprotective efficacy of artocarpin across in vitro, in vivo and clinical study, based on the peer-reviewed literature published between 2012 and 2025, retrieved from PubMed, Scopus, and Web of Science. Delivery strategies designed to overcome the inherent physicochemical limitations of artocarpin on skin penetration are also discussed. Artocarpin demonstrates antioxidant effects through both direct free radical scavenging and activation of the Nrf2-ARE pathway, providing sustained cellular defense. Its anti-inflammatory properties target multiple signaling cascades, including the NF-κB and MAPK pathways, effectively mitigating UV-induced inflammatory response. The compound maintains dermal matrix homeostasis by inhibiting matrix metalloproteinase-1 (MMP-1) expression while preserving collagen synthesis and fibroblast mechanical function. Additionally, artocarpin exhibits selective apoptosis modulation, being cytoprotective in normal keratinocytes while acting as pro-apoptotic in damaged or abnormal cells, thereby supporting tissue homeostasis. It also inhibits melanogenesis through anti-inflammatory mechanisms rather than direct tyrosinase inhibition. Furthermore, artocarpin has been shown to induce autophagic cell death in certain cell lines; however, its role in UV-induced skin damages remains to be clarified. Despite these promising biological activities, the poor water solubility (<0.1 mg/mL) and high lipophilicity (log P ≈ 5) of artocarpin significantly limit its skin penetration. Lipid-based delivery systems, including liposomes, transfersomes, ethosomes, and nanostructured lipid carriers (NLCs), are presented as effective strategies to enhance transepidermal delivery, with each system offering distinct mechanistic advantages. Further investigations should prioritize the safety of artocarpin within each delivery system, as well as the synergistic co-encapsulation with complementary natural antioxidants to simultaneously target multiple mechanisms involved in UV-induced skin damage, thereby broadening its application in the cosmeceutical industry.
Open AccessArtocarpin: Multi-Targeted Mechanisms Against UV-Induced Skin Aging and Its Skin Penetration Enhancement Strategies
Artocarpin, a prenylated flavonoid isolated from Artocarpus altilis heartwood, has emerged as a promising multi-targeted bioactive compound for combating UV-induced skin aging. This review provides a comprehensive overview of the molecular mechanisms and photoprotective efficacy of artocarpin across in vitro, in vivo and clinical study, based on the peer-reviewed literature published between 2012 and 2025, retrieved from PubMed, Scopus, and Web of Science. Delivery strategies designed to overcome the inherent physicochemical limitations of artocarpin on skin penetration are also discussed. Artocarpin demonstrates antioxidant effects through both direct free radical scavenging and activation of the Nrf2-ARE pathway, providing sustained cellular defense. Its anti-inflammatory properties target multiple signaling cascades, including the NF-κB and MAPK pathways, effectively mitigating UV-induced inflammatory response. The compound maintains dermal matrix homeostasis by inhibiting matrix metalloproteinase-1 (MMP-1) expression while preserving collagen synthesis and fibroblast mechanical function. Additionally, artocarpin exhibits selective apoptosis modulation, being cytoprotective in normal keratinocytes while acting as pro-apoptotic in damaged or abnormal cells, thereby supporting tissue homeostasis. It also inhibits melanogenesis through anti-inflammatory mechanisms rather than direct tyrosinase inhibition. Furthermore, artocarpin has been shown to induce autophagic cell death in certain cell lines; however, its role in UV-induced skin damages remains to be clarified. Despite these promising biological activities, the poor water solubility (<0.1 mg/mL) and high lipophilicity (log P ≈ 5) of artocarpin significantly limit its skin penetration. Lipid-based delivery systems, including liposomes, transfersomes, ethosomes, and nanostructured lipid carriers (NLCs), are presented as effective strategies to enhance transepidermal delivery, with each system offering distinct mechanistic advantages. Further investigations should prioritize the safety of artocarpin within each delivery system, as well as the synergistic co-encapsulation with complementary natural antioxidants to simultaneously target multiple mechanisms involved in UV-induced skin damage, thereby broadening its application in the cosmeceutical industry.
- Open Access
Characterization and Migration Activity of Thermoresponsive Silk Fibroin–Aloe Vera Gel in Normal and Diabetic Fibroblasts
Diabetic wounds remain a major clinical challenge due to delayed healing caused by chronic inflammation and impaired fibroblast activity. Here, we present a thermoresponsive gel composed of chitosan (CS) and poloxamers (POL) incorporating silk fibroin (SFB) and Aloe vera gel extract (AV), developed for topical application and, for the first time, evaluated using an inflammation-induced diabetic fibroblast model. The optimized formulation exhibited rapid sol–gel transition at physiological temperature and suitable rheological properties for effective wound coverage. In vitro evaluation using human normal fibroblasts (HNF) and human diabetic fibroblasts (HDF), under both basal and inflammation-induced conditions, demonstrated good cytocompatibility and a significant enhancement of fibroblast migration, particularly in an inflammatory microenvironment simulated by high glucose, lipopolysaccharide (LPS), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α). These findings highlight the potential of the developed thermoresponsive gel as a promising biomaterial platform for improving diabetic wound healing under inflammation-relevant conditions.
Open AccessCharacterization and Migration Activity of Thermoresponsive Silk Fibroin–Aloe Vera Gel in Normal and Diabetic Fibroblasts
Diabetic wounds remain a major clinical challenge due to delayed healing caused by chronic inflammation and impaired fibroblast activity. Here, we present a thermoresponsive gel composed of chitosan (CS) and poloxamers (POL) incorporating silk fibroin (SFB) and Aloe vera gel extract (AV), developed for topical application and, for the first time, evaluated using an inflammation-induced diabetic fibroblast model. The optimized formulation exhibited rapid sol–gel transition at physiological temperature and suitable rheological properties for effective wound coverage. In vitro evaluation using human normal fibroblasts (HNF) and human diabetic fibroblasts (HDF), under both basal and inflammation-induced conditions, demonstrated good cytocompatibility and a significant enhancement of fibroblast migration, particularly in an inflammatory microenvironment simulated by high glucose, lipopolysaccharide (LPS), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α). These findings highlight the potential of the developed thermoresponsive gel as a promising biomaterial platform for improving diabetic wound healing under inflammation-relevant conditions.
- Open Access
Development of Artocarpin-Loaded Chitosan Particles for Controlled Release and Inflammatory Application
Artocarpin, a flavonoid derived from Artocarpus altilis, has been reported to exhibit anti-inflammatory and geroprotective activities. In this study, artocarpin was isolated from A. altilis heartwood via maceration followed by chromatographic purification, yielding 0.435% of dried extract with a purity of approximately 81%, as confirmed by HPLC. To enhance the physicochemical stability and biological performance of artocarpin, a chitosan-based microparticle delivery system was developed using 0.1% chitosan cross-linked with 0.5% sodium tripolyphosphate (5:1 ratio). The optimized formulation achieved an encapsulation efficiency of 0.5 µg of artocarpin per mg of particles (loading content 0.05% w/w). Physicochemical analysis revealed that the particles possessed a predominantly spherical morphology with sizes ranging from 1 to 4 µm. The hydrodynamic diameter measured by DLS was approximately 3.3 µm, with a PDI of 0.79 ± 0.18 and a zeta potential of 12.8 mV, indicating acceptable dispersity and colloidal stability for a chitosan-based microparticle system. FTIR and XRD analyses verified successful incorporation of artocarpin into the chitosan matrix. In vitro release studies showed a biphasic pattern with an initial burst within 1–12 h followed by sustained release, reaching approximately 60% cumulative release. The anti-inflammatory activity of the formulations was evident through a dose-dependent reduction in nitric oxide production in LPS-stimulated RAW 264.7 macrophages. The artocarpin-loaded particles (CSPs/AE) suppressed NO levels by 34.33 to 73.19%, with statistically significant decreases at p < 0.05. These results highlight the potential of artocarpin-loaded chitosan microparticles as an effective anti-inflammatory delivery system with promising applicability for osteoarthritis management.
Open AccessDevelopment of Artocarpin-Loaded Chitosan Particles for Controlled Release and Inflammatory Application
Artocarpin, a flavonoid derived from Artocarpus altilis, has been reported to exhibit anti-inflammatory and geroprotective activities. In this study, artocarpin was isolated from A. altilis heartwood via maceration followed by chromatographic purification, yielding 0.435% of dried extract with a purity of approximately 81%, as confirmed by HPLC. To enhance the physicochemical stability and biological performance of artocarpin, a chitosan-based microparticle delivery system was developed using 0.1% chitosan cross-linked with 0.5% sodium tripolyphosphate (5:1 ratio). The optimized formulation achieved an encapsulation efficiency of 0.5 µg of artocarpin per mg of particles (loading content 0.05% w/w). Physicochemical analysis revealed that the particles possessed a predominantly spherical morphology with sizes ranging from 1 to 4 µm. The hydrodynamic diameter measured by DLS was approximately 3.3 µm, with a PDI of 0.79 ± 0.18 and a zeta potential of 12.8 mV, indicating acceptable dispersity and colloidal stability for a chitosan-based microparticle system. FTIR and XRD analyses verified successful incorporation of artocarpin into the chitosan matrix. In vitro release studies showed a biphasic pattern with an initial burst within 1–12 h followed by sustained release, reaching approximately 60% cumulative release. The anti-inflammatory activity of the formulations was evident through a dose-dependent reduction in nitric oxide production in LPS-stimulated RAW 264.7 macrophages. The artocarpin-loaded particles (CSPs/AE) suppressed NO levels by 34.33 to 73.19%, with statistically significant decreases at p < 0.05. These results highlight the potential of artocarpin-loaded chitosan microparticles as an effective anti-inflammatory delivery system with promising applicability for osteoarthritis management.
- Open Access
Ternary Blends of PLA with ATEC and TMC-200 as Medical-Grade Biodegradable Monofilaments for FDM 3D-Printing Applications
Poly(L-lactide) (PLA) is a promising biopolymer for biomedical applications due to its biodegradability and biocompatibility; however, its brittleness restricts its use in fused deposition modeling (FDM). To overcome this limitation, flexible PLA monofilaments with enhanced mechanical performance and printability were developed. In this study, PLA was melt-blended with acetyl triethyl citrate (ATEC, 1.0–5.0 wt%) as a plasticizer and zinc phenyl phosphonate (TMC-200, 0.3 wt%) as a nucleating agent. It was found that the PLA with 3.0 wt% ATEC (PLA/A) exhibited the greatest flexibility, while the addition of TMC-200 further improved tensile strength and ductility. Specifically, the ternary blend of PLA/TMC-200/ATEC (PLA/T/A) exhibited a synergistic effect, achieving superior mechanical properties (tensile strength: 35.0 MPa, elongation at break: 232.0%, compared to 12.1% for pure PLA) and raising the degree of crystallinity (Xc) from 4.7% to 45.0%. Monofilaments (1.70 ± 0.05 mm) fabricated from PLA/T/A exhibited smooth surfaces, balanced mechanical performance, and excellent cytocompatibility (over 99% cell viability in L929 fibroblasts). Moreover, FDM-printed specimens retained enhanced mechanical and thermal performance, demonstrating material stability after processing. Shelf-life testing further confirmed the structural integrity of PLA/T/A monofilament after 8 weeks at 50 °C. Overall, PLA/T/A provides an effective strategy for producing high-performance, medical-grade PLA monofilaments with improved toughness, printability, and biocompatibility, enabling their application in biomedical 3D printing.
Open AccessTernary Blends of PLA with ATEC and TMC-200 as Medical-Grade Biodegradable Monofilaments for FDM 3D-Printing Applications
Poly(L-lactide) (PLA) is a promising biopolymer for biomedical applications due to its biodegradability and biocompatibility; however, its brittleness restricts its use in fused deposition modeling (FDM). To overcome this limitation, flexible PLA monofilaments with enhanced mechanical performance and printability were developed. In this study, PLA was melt-blended with acetyl triethyl citrate (ATEC, 1.0–5.0 wt%) as a plasticizer and zinc phenyl phosphonate (TMC-200, 0.3 wt%) as a nucleating agent. It was found that the PLA with 3.0 wt% ATEC (PLA/A) exhibited the greatest flexibility, while the addition of TMC-200 further improved tensile strength and ductility. Specifically, the ternary blend of PLA/TMC-200/ATEC (PLA/T/A) exhibited a synergistic effect, achieving superior mechanical properties (tensile strength: 35.0 MPa, elongation at break: 232.0%, compared to 12.1% for pure PLA) and raising the degree of crystallinity (Xc) from 4.7% to 45.0%. Monofilaments (1.70 ± 0.05 mm) fabricated from PLA/T/A exhibited smooth surfaces, balanced mechanical performance, and excellent cytocompatibility (over 99% cell viability in L929 fibroblasts). Moreover, FDM-printed specimens retained enhanced mechanical and thermal performance, demonstrating material stability after processing. Shelf-life testing further confirmed the structural integrity of PLA/T/A monofilament after 8 weeks at 50 °C. Overall, PLA/T/A provides an effective strategy for producing high-performance, medical-grade PLA monofilaments with improved toughness, printability, and biocompatibility, enabling their application in biomedical 3D printing.
- 16 September 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 329 (Pt 1) , 147702
Starburst-like nanogels from vinyl-functionalized poly(lactic acid) and silk sericin via Aloe vera gel extract–mediated self-assembly: Toward multifunctional natural polymer nanomaterials
- 16 September 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 329 (Pt 1) , 147702
Starburst-like nanogels from vinyl-functionalized poly(lactic acid) and silk sericin via Aloe vera gel extract–mediated self-assembly: Toward multifunctional natural polymer nanomaterials